The Clorox Company $CLX Shares Acquired by Pacific Point Advisors LLC

Pacific Point Advisors LLC increased its stake in shares of The Clorox Company (NYSE:CLX) by 2.7% during the second quarter, Holdings Channel.com reports. The institutional investor owned 9,686 shares of the company’s stock after buying an additional 259 shares during the quarter. Pacific Point Advisors LLC’s holdings in Clorox were worth $1,163,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in CLX. Raymond James Financial Inc. grew its stake in Clorox by 15.6% during the 1st quarter. Raymond James Financial Inc. now owns 269,926 shares of the company’s stock valued at $39,747,000 after purchasing an additional 36,352 shares during the last quarter. OneDigital Investment Advisors LLC acquired a new stake in shares of Clorox during the first quarter worth about $247,000. Brown Miller Wealth Management LLC acquired a new stake in shares of Clorox during the first quarter worth about $399,000. Roman Butler Fullerton & Co. acquired a new position in Clorox in the 1st quarter worth approximately $400,000. Finally, Wedge Capital Management L L P NC increased its holdings in Clorox by 33.5% in the 1st quarter. Wedge Capital Management L L P NC now owns 28,510 shares of the company’s stock worth $4,198,000 after buying an additional 7,159 shares during the period. Hedge funds and other institutional investors own 78.53% of the company’s stock.

Clorox Trading Up 0.3%

CLX stock opened at $123.32 on Wednesday. The company’s 50-day simple moving average is $123.33 and its 200-day simple moving average is $130.02. The company has a quick ratio of 0.57, a current ratio of 0.84 and a debt-to-equity ratio of 5.15. The Clorox Company has a 52-week low of $116.53 and a 52-week high of $171.37. The firm has a market cap of $15.08 billion, a P/E ratio of 18.91, a PEG ratio of 0.99 and a beta of 0.52.

Clorox (NYSE:CLX) last announced its quarterly earnings results on Thursday, July 31st. The company reported $2.87 earnings per share for the quarter, beating the consensus estimate of $2.24 by $0.63. The firm had revenue of $1.99 billion during the quarter, compared to analyst estimates of $1.94 billion. Clorox had a return on equity of 377.86% and a net margin of 11.40%.Clorox’s revenue for the quarter was up 4.5% compared to the same quarter last year. During the same quarter in the previous year, the business earned $1.82 EPS. Clorox has set its FY 2026 guidance at 5.950-6.30 EPS. As a group, equities analysts forecast that The Clorox Company will post 7.15 EPS for the current fiscal year.

Clorox Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Thursday, November 6th. Stockholders of record on Wednesday, October 22nd will be given a dividend of $1.24 per share. The ex-dividend date is Wednesday, October 22nd. This represents a $4.96 dividend on an annualized basis and a dividend yield of 4.0%. Clorox’s dividend payout ratio (DPR) is 76.07%.

Analysts Set New Price Targets

Several analysts have commented on CLX shares. Barclays decreased their price objective on shares of Clorox from $118.00 to $112.00 and set an “underweight” rating for the company in a research note on Tuesday. Zacks Research upgraded shares of Clorox from a “strong sell” rating to a “hold” rating in a research report on Monday. Jefferies Financial Group lowered their price target on shares of Clorox from $167.00 to $145.00 and set a “buy” rating on the stock in a report on Thursday, June 26th. UBS Group reduced their price objective on Clorox from $150.00 to $134.00 and set a “neutral” rating for the company in a research note on Thursday, July 17th. Finally, Wells Fargo & Company decreased their price objective on Clorox from $130.00 to $125.00 and set an “equal weight” rating for the company in a report on Thursday, September 25th. One investment analyst has rated the stock with a Buy rating, nine have assigned a Hold rating and two have assigned a Sell rating to the company. According to data from MarketBeat.com, Clorox presently has a consensus rating of “Reduce” and an average price target of $141.09.

Insider Transactions at Clorox

In related news, COO Eric H. Reynolds sold 15,041 shares of Clorox stock in a transaction on Thursday, September 4th. The shares were sold at an average price of $123.78, for a total value of $1,861,774.98. Following the sale, the chief operating officer owned 54,221 shares of the company’s stock, valued at approximately $6,711,475.38. This trade represents a 21.72% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Corporate insiders own 0.57% of the company’s stock.

About Clorox

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.